Deaths Prompt Pfizer to End Cholesterol Drug Trials
683010
NEW YORK, Dec. 2 -- Pfizer Inc. announced Saturday that it has cut off all clinical trials and development work for a cholesterol drug that was supposed to be a star product because of an unexpected number of deaths and cardiovascular problems among patients who used it.
357920
Pfizer Inc. on Friday said patients  taking its blockbuster arthritis drug Celebrex in a long-term  cancer-prevention trial had more than twice the number of fatal  or non-fatal heart attacks as those taking a placebo.
411818
A drug combination that produced such positive results in clinical trials that they were stopped before their scheduled completion date reduces death from coronary heart disease by up to 43 percent, a new study reports.
5618
A combination drug targeted at African-Americans has dramatically reduced deaths from heart disease in trials, paving the way for a new debate over the potential for &quot;ethnic treatments&quot;.
756760
Decode Genetics Inc. said on Thursday  it was halting its late-stage clinical trial program for an  experimental oral heart attack drug after a formulation problem  with the tablets cropped up.
224987
Doctors should limit use of Pfizer Inc.&#39;s Celebrex and Bextra pain drugs while regulators continue to weigh their cardiovascular risks, the US Food and Drug Administration said.
211271
Aug. 20 (Bloomberg) -- Antidepressant drugmakers such as Pfizer Inc., GlaxoSmithKline Plc and Wyeth will have to disclose trial results suggesting a higher risk of suicide among children and teenagers taking the pills, US regulators said.
609249
Aug. 20 (Bloomberg) -- Pfizer Inc.&#39;s Lipitor cholesterol reducer, the world&#39;s top-selling drug, cut heart attacks and strokes by more than a third for diabetics who didn&#39;t start out with high levels of so-called bad cholesterol, the British medical ...
74465
Pharmaceutical giant Pfizer Inc. said Wednesday that a long-term study of its Norvasc blood pressure treatment in patients with other heart disease risks was stopped early because of the drug&#39;s significant benefits.
288359
Pfizer Inc. on Friday said a government-sponsored cancer-prevention trial of its blockbuster arthritis drug Celebrex was halted after patients taking it had more than
729710
Citing the &quot;interests of patient safety,&quot; US drug manufacturer Pfizer said it was stopping all clinical trials of the cholesterol-controlling drug Torcetrapib.
424951
NEW YORK - A new round of trials have shown a boosted risk of heart problems among patients taking the painkiller Celebrex, manufacturer Pfizer Inc.
475207
United States drug giant Pfizer says a trial has found a sharp rise in heart attacks for patients using its blockbuster Celebrex arthritis and pain medicine.
127685
FRIDAY, Dec. 17 (HealthDayNews) -- The U.S. government announced Friday it has  halted the use of Celebrex in a cancer trial because of heart risks, and it is reviewing the safety of all its clinical trials using similar painkillers.
722145
Will Pfizer be able to offset the looming loss of Lipitor?
57054
Pfizer Inc., the world&#39;s biggest drugmaker, said it will stop advertising its Celebrex painkiller to consumers after a study showed the drug more than doubled the risk of heart attacks when given in high doses.
83148
A popular cholesterol-lowering drug failed to help slow the buildup of artery-clogging plaque in a long-awaited study, the companies that market the medication said yesterday, raising questions about whether its use should be limited.